Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C

NCT04166058 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

381

Enrollment

INDUSTRY

Sponsor class

Conditions

Irritable Bowel Syndrome With Constipation
Functional Constipation

Interventions

DRUG: Irritable Bowel Syndrome with Constipation (IBS-C) participants (LIN-MD-63 and LIN-MD-64 completers)
DRUG: Functional Constipation (FC) participants (LIN-MD-62 and LIN-MD-64 completers)

Sponsor

AbbVie

Collaborators

[object Object]